Autopsy report · NCT06646328
Oxidative Stress and Circulating Nuclear DNA (cfDNA) in Acute Kidney Injury and Continuous Renal Replacement Therapies.
Cause of deathStaffing, sites or logistics, also slow enrollment
“Enrollment slower than anticipated and interrupted by COVID-19 pandemic”
Life of this trial
- Registered 2 months after it had already started.
- Ran for about 2 years 11 months before it stopped.
- 20 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 4
- Sponsor
- Fernando Sanchez
- Sponsor type
- University, hospital or other
- Conditions
- Acute Kidney Injury
- Interventions
- Central venous access; Pump-assisted circuit; Heparin sodium; Regional citrate anticoagulation; Blood and ultrafiltrate samples
- Participants
- 20
- Sites
- 1
- Countries
- Spain
Trials that died the same way
- Pro-permeability and Pro-fibrosis Factors in the Aqueous of Patients With Retinal Diseases
“Enrollment was affected due to the COVID-19 pandemic” - Quality of Life Changes on Lower Extremity Lymphedema Patients Using an Advanced Pneumatic Compression Device (PCD)
“Due to slow enrollment during COVID” - Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes
“Enrollment halted prematurely due to the Covid-19 pandemic” - Study of Latiglutenase in T1D/CD Patients
“Covid-19 interruptions and enrollment challenges” - Zileuton CR vs Placebo in Poorly Controlled Asthma Patients on Moderate Dose ICS
“Slower than anticipated enrollment”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.